More Resources | Manufacturer Actions

Manufacturer Notices

These are copies of the actual notices that prompted or align with our communications:

AbbVie (12/2021)
AbbVie Imbruvica (3/2022)
Abbvie (04/2023)
Amgen (12/2020)
Amgen (12/2021)
Amgen (04/2023)
AstraZeneca - Covered Entities (08/2020)
AstraZeneca - Orphan Drug (5/2022)
AstraZeneca - Retail (08/2020)
Bausch Health - Amerisource Bergen (12/2020)
Bausch Health - Amerisource Bergen (02/2021)
Bausch Health (08/2022)
Bayer (03/2023)
Bayer (06/2023)
Biogen (12/2022)
Boehringer Ingelheim (06/2021)
Boehringer Ingelheim OFEV (12/2021)
Bristol Myers Squibb (01/2022)
Eli Lilly (09/2020)
Eli Lilly (10/2020)
Eli Lilly 340B ESP (12/2021)
EMD Serono (03/2023)
Exelixis (06/2022)
Exelixis FAQ
Gilead (3/2022)
GlaxoSmithKline (02/2022)
GlaxoSmithKline Orphan Drug (07/2022)
GlaxoSmithKline (05/2023)
Janssen Orphan Drug (11/2021)
Johnson&Johnson (3/2022)
Johnson&Johnson (3/2023)
Merck (08/2021)
Merck (06/2020)
Merck (03/2021)
Merck (4/2022)
Merck (06/2023)
Novartis Fact Sheet (08/2020)
Novartis (10/2020)
Novartis (05/2023)
Novo Nordisk (12/2020)
Novo Nordisk (1/2023)
Novo Nordisk (07/2023)
Organon (07/2023)
Pfizer (01/2022)
Pfizer (05/2023)
Sanofi (02/2021)
Sanofi (10/2020)
Sanofi (07/2020)
Sanofi (06/2023)
UCB (12/2021)
United Therapeutics (11/2020)
United Therapeutics (05/2021)
United Therapeutics (07/2021)